��������

David Hoyos is the Director of Business Development and M&A at Repligen Corporation, a position they have held since 2024. Previously, they served as the Director of Corporate Development at Catalent Pharma Solutions from 2021 to 2024 and as Vice President of Healthcare Investment Banking at RBC Capital Markets from 2019 to 2021. They began their career at Deutsche Bank as a Summer Analyst in 2008 and later worked at Wells Fargo Securities and Piper Jaffray in various roles. David holds a Bachelor's Degree in Economics from Drew University, graduating Magna Cum Laude, and an M.B.A. in Finance, Real Estate, and Entrepreneurship & Innovation from New York University's Leonard N. Stern School of Business.